Reverse Genetic H9N2 Influenza Vaccine Study in Adults

NCT01320696 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

353

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Reverse Genetic (RG) reassortant A/H9N2 influenza vaccine

Sponsor

Alachua Government Services, Inc.